| Product sales | 19.23M |
| System sales | 1.96M |
| Revenues from product development agreements | 659K |
| License and other revenues | 106K |
| Total Revenues | 21.96M |
| Cost of product sales | 23.6M |
| Cost of system sales | 2.44M |
| Cost of revenues from product development agreements | 297K |
| Product development and research | 1.34M |
| Preproduction costs | 94K |
| Selling, general and administrative | 11M |
| Net (gain) loss on disposal of property, plant and equipment | 0 |
| Impairment loss | 34.28M |
| Restructuring charges | -27K |
| Total Expenses | 73.01M |
| Operating Loss from Continuing Operations | -51.06M |
| Interest income | 1.5M |
| Interest expense | -5.81M |
| Gain on debt extinguishment | 0 |
| Other nonoperating income (expense), net | -1.47M |
| Total Other Expense | -5.78M |
| Loss before Income Taxes and Equity Loss from Continuing Operations | -56.84M |
| Income tax expense | 506K |
| Loss from Continuing Operations before Equity Loss | -57.34M |
| Equity loss | -118K |
| Net Loss from Continuing Operations | -57.46M |
| Income from Discontinued Operations, Net of Tax | 1.34M |
| Net Loss | -56.12M |
| Net Loss Attributable to Noncontrolling Interest | -99K |
| Net Loss Attributable to ECD Stockholders | -56.02M |
| Loss Per Share from Continuing Operations | -1.15 |
| Income Per Share from Discontinued Operations | 0.03 |
| Loss Per Share, Attributable to ECD Stockholders | -1.12 |
| Diluted Loss Per Share from Continuing Operations | -1.15 |
| Diluted Income Per Share from Discontinued Operations | 0.03 |
| Diluted Loss Per Share, Attributable to ECD Stockholders | -1.12 |